Gravity Analytica

Enliven Therapeutics to Present at the Jefferies London Healthcare Conference

ELVN 11.07.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-19

Name of Upcoming Event:Jefferies London Healthcare Conference

Full Press Release SEC Filings Our ELVN Tweets

About Gravity Analytica

Recent Filings

BOULDER, Colo.,Nov. 7, 2024/PRNewswire/ --Enliven Therapeutics, Inc.(Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that management will participate in a fireside chat at theJefferies London Healthcare ConferenceonTuesday, November 19, 2024, at9:30 a.m. GMT. The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website athttps://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.

About EnlivenEnliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people with cancer not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based inBoulder, Colorado.

View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-jefferies-london-healthcare-conference-302299207.html

SOURCEEnliven Therapeutics, Inc.

Contact:Investorsir@enliventherapeutics.com

Mediamedia@enliventherapeutics.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com